Valiant Laboratories Limited (NSE:VALIANTLAB)

Valiant Laboratories Revenue

Valiant Laboratories had revenue of 1.15B INR in the quarter ending June 30, 2026, with 146.22% growth. This brings the company's revenue in the last twelve months to 3.06B, up 89.64% year-over-year. In the fiscal year ending March 31, 2026, Valiant Laboratories had annual revenue of 2.37B with 78.04% growth.

• Revenue (ttm): 3.06B
• Revenue Growth: +89.64%
• P/S Ratio: 2.03
• Revenue / Employee: 36.42M
• Employees: 79
• Market Cap: 6.20B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.37B	1.04B	78.04%
Mar 31, 2025	1.33B	-486.75M	-26.74%
Mar 31, 2024	1.82B	-1.52B	-45.48%
Mar 31, 2023	3.34B	215.43M	6.90%
Mar 31, 2022	3.12B	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error